free性video西欧极品,伊人依成久久人综合网,中文字幕人妻一区二区三区熟女,男女高潮激烈无遮挡免费观软件 ,成人3d动漫一区二区三区

  • Mallinckrodt Completes Acquisition of Ocera Therapeutics, OCR-002 americanpharmaceuticalreview
    December 12, 2017
    Mallinckrodt has closed the acquisition of Ocera Therapeutics, a clinical-phase biopharmaceutical company focused on the development and commercialization of novel therapeutic drugs for orphans and other serious liver diseases that have not been met
  • Mallinckrodt to Acquire Ocera Therapeutics, OCR-002 americanpharmaceuticacreview
    November 03, 2017
    The FDA granted OCR-002 its Orphan Drug Designation, and the resulting seven years' exclusivity would be applied upon first approval of the drug.

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194
+86 15021993094

PharmaSources Customer Service